LXRX icon

Lexicon Pharmaceuticals
LXRX

Overview Fund Activity

127 hedge funds and large institutions have $122M invested in Lexicon Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 34 increasing their positions, 32 reducing their positions, and 29 closing their positions.

Holders
127
Holders Change
+1
Holders Change %
+0.79%
% of All Funds
1.73%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
32
Increased
34
Reduced
32
Closed
29
Calls
$358K
Puts
$52K
Net Calls
+$306K
Net Calls Change
-$78K

Top Buyers

1
CIBC Private Wealth Group
1
CIBC Private Wealth Group
Georgia
$1.12M
2
UBS Group
2
UBS Group
Switzerland
$966K
3
AQR Capital Management
3
AQR Capital Management
Connecticut
$541K
4
GCP
4
GSA Capital Partners
United Kingdom
$372K
5
MAM
5
Monaco Asset Management
Monaco
$338K

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$15.9M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$0
3
NCM
3
Nantahala Capital Management
Connecticut
$212K
4
NMC
4
NEA Management Company
Maryland
$0
5
PA
5
Pinnacle Associates
New York
$25K
Name Holding Trade Value Shares
Change 		Shares
Change %
RS
151
R Squared
Hong Kong
– -$2.25K -3,040 Closed
MCM
152
Manchester Capital Management
Vermont
– -$1.76K -2,380 Closed
S
153
SignatureFD
Georgia
– -$287 -388 Closed
CAS
154
Coppell Advisory Solutions
Texas
– -$37 -52 Closed
3 4 5 6
7